Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cahill

Showing results (331-340 of 425) with videos related to

Pageof 43
Sort By:
Neurosurgery|November 5, 2025
Multi-Institutional Assessment of Circulating Cell-Free DNA in Cerebrospinal Fluid Facilitates Central Nervous System Lymphoma Diagnosis and Treatment InitiationBriana C Prager, Mihir Gupta, Timothy R West, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2020
The SrrAB two-component system regulates <i>Staphylococcus aureus</i> pathogenicity through redox sensitive cysteinesNitija Tiwari, Marisa López-Redondo, Laura Miguel-Romero, et al.
The Lancet. Oncology|August 30, 2024
The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect groupPhilipp Karschnia, Jasper K W Gerritsen, Nico Teske, et al.
Neurosurgery|November 28, 2018
A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in CraniopharyngiomasShingo Fujio, Tareq A Juratli, Kazunori Arita, et al.
Cancer Research|May 6, 2004
Three classes of genes mutated in colorectal cancers with chromosomal instabilityZhenghe Wang, Jordan M Cummins, Dong Shen, et al.
Neuro-Oncology|December 6, 2013
Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshopJason T Huse, Max Wallace, Kenneth D Aldape, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2014
Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomasHiroaki Wakimoto, Shota Tanaka, William T Curry, et al.
Journal of the National Cancer Institute|October 27, 2015
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted TherapyPriscilla K Brastianos, Ganesh M Shankar, Corey M Gill, et al.
Neuro-Oncology|January 25, 2026
Cognitive Function, Quality of Life, and Survival Outcomes in Patients with Lower Grade Gliomas Treated with Proton Radiation Therapy: A Phase II studyJason M Slater, Nora K Horick, Lisa B Nachtigall, et al.
Nature Biotechnology|July 24, 2019
CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicityBryan D Choi, Xiaoling Yu, Ana P Castano, et al.
Pageof 43

Showing results (331-340 of 425) with videos related to

Sort By:
Pageof 43
Neurosurgery|November 5, 2025
Multi-Institutional Assessment of Circulating Cell-Free DNA in Cerebrospinal Fluid Facilitates Central Nervous System Lymphoma Diagnosis and Treatment InitiationBriana C Prager, Mihir Gupta, Timothy R West, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2020
The SrrAB two-component system regulates <i>Staphylococcus aureus</i> pathogenicity through redox sensitive cysteinesNitija Tiwari, Marisa López-Redondo, Laura Miguel-Romero, et al.
The Lancet. Oncology|August 30, 2024
The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect groupPhilipp Karschnia, Jasper K W Gerritsen, Nico Teske, et al.
Neurosurgery|November 28, 2018
A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in CraniopharyngiomasShingo Fujio, Tareq A Juratli, Kazunori Arita, et al.
Cancer Research|May 6, 2004
Three classes of genes mutated in colorectal cancers with chromosomal instabilityZhenghe Wang, Jordan M Cummins, Dong Shen, et al.
Neuro-Oncology|December 6, 2013
Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshopJason T Huse, Max Wallace, Kenneth D Aldape, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2014
Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomasHiroaki Wakimoto, Shota Tanaka, William T Curry, et al.
Journal of the National Cancer Institute|October 27, 2015
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted TherapyPriscilla K Brastianos, Ganesh M Shankar, Corey M Gill, et al.
Neuro-Oncology|January 25, 2026
Cognitive Function, Quality of Life, and Survival Outcomes in Patients with Lower Grade Gliomas Treated with Proton Radiation Therapy: A Phase II studyJason M Slater, Nora K Horick, Lisa B Nachtigall, et al.
Nature Biotechnology|July 24, 2019
CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicityBryan D Choi, Xiaoling Yu, Ana P Castano, et al.
Pageof 43